Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer

Health and Quality of Life Outcomes

Volumn 10, Issue , 2012, Pages

  Bosco, Jaclyn L F ^a   Halpenny, Barbara ^a   Berry, Donna L ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Decision making; Localized prostate cancer; Patient preferences; Quality of life; Randomized trial; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER FUNCTION; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER PROGRAM; CONSULTATION; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT DECISION MAKING; PATIENT EDUCATION; PATIENT PREFERENCE; PATIENT PROFILE PROSTATE; PHYSICIAN; PROSTATE CANCER; PROSTATECTOMY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SEXUAL FUNCTION; WEB BROWSER;

CHOICE BEHAVIOR; CONTROL GROUPS; DECISION SUPPORT SYSTEMS, CLINICAL; FECAL INCONTINENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOGISTIC MODELS; MALE; PATIENT PREFERENCE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SOCIOECONOMIC FACTORS; UNITED STATES; URINARY INCONTINENCE, STRESS; USER-COMPUTER INTERFACE;

EID: 84866635490     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-10-123     Document Type: Article

References (24)

1. Mauger Rothenberg B, Marbella A, Belinson SE, Samson DJ, Bonnell CJ, Ziegler KM, Aronson N. Future Research Needs for Comparative Effectiveness of Treatments for Localized Prostate Cancer. Future Research Needs Paper No. 4. (Prepared by Blue Cross and Blue Shield Association, Technology Evaluation Center Evidence-based Practice Center under Contract No. 290-2007-10058-I.). 2010, Agency for Healthcare Research and Quality, Rockville, MD, Available at: www.effectivehealthcare.ahrq.gov/reports/final.cfm.
2. Holmboe ES, Concato J. Treatment decisions for localized prostate cancer: asking men what's important. J Gen Intern Med 2000, 15:694-701. 10.1046/j.1525-1497.2000.90842.x, 1495597, 11089712.
3. Zeliadt SB, Ramsey SD, Penson DF, Hall IJ, Ekwueme DU, Stroud L, Lee JW. Why do men choose one treatment over another?. Cancer 2006, 106(9):1865-1874. 10.1002/cncr.21822, 16568450.
4. Branney P, White A, Jain S, Hiley C, Flowers P. Choosing Health, Choosing Treatment: Patient Choice After Diagnosis of Localized Prostate Cancer. Urology 2009, 74(5):968-971. 10.1016/j.urology.2009.03.015, 19883806.
5. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, et al. Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors. N Engl J Med 2008, 358(12):1250-1261. 10.1056/NEJMoa074311, 18354103.
6. Wilt T. The VA/NCI/AHRQ CSP #407: Prostate Cancer Intervention Versus Observation Trial (PIVOT): Main Results From a Randomized Trial Comparing Radical Prostatectomy to Watchful Waiting in Men With Clinically Localized Prostate Cancer. 2011, American Urological Association (AUA) Annual Meeting: May 14-19, 2011 2011, Washington D.C.
7. Beydoun HA, Mohan R, Beydoun MA, Davis J, Lance R, Schellhammer P. Development of a scale to assess patient misperceptions about treatment choices for localized prostate cancer. BJU Int 2010, 106(3):334-341. 10.1111/j.1464-410X.2010.09209.x, 2888927, 20151969.
8. Barry MJ. The Prostate Cancer Treatment Bazaar: Comment on "Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer". Arch Intern Med 2010, 170(5):450-452. 10.1001/archinternmed.2010.2, 20212181.
9. Evans C, Dawe R, Carson-Stevens A, Re B, et al. Choosing Health, Choosing Treatment: Patient Choice After Diagnosis of Localized Prostate Cancer (Urology 2009;74:968-971). Urology 2010, 75(3):751-751.
10. Berry DL, Ellis WJ, Woods NF, Schwien C, Mullen KH, Yang CC. Treatment decision-making by men with localized prostate cancer: the influence of personal factors. Urol Oncol 2003, 21(2):93-100. 10.1016/S1078-1439(02)00209-0, 12856636.
11. O'Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth G, McPherson R, Bunn H, Graham I, Drake E. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns 1998, 33(3):267-279. 10.1016/S0738-3991(98)00026-3, 9731164.
12. Berry DL, Halpenny B, Hong F, Wolpin S, Lober WB, Russell KJ, Ellis WJ, Govindarajulu U, Bosco J, Davison BJ, et al. The Personal Patient Profile-Prostate for men with newly diagnosed localized prostate cancer: a multi-site randomized trial. Urol Oncol 2011, Dec 7, Epub ahead of print. PMID 22153756.
13. Berry DL, Halpenny BSW, Davison BJ, Ellis WJ, Lober WB, McReynolds J, Wulff J. Development and evaluation of the personal patient profile-prostate (P3P), a Web-based decision support system for men newly diagnosed with localized prostate cancer. J Med Internet Res 2010, 12:67.
14. Spielberger C. State-Trait Anxiety Inventory for Adults (Form Y). 1993, Mind Garden, Inc, Palo Alto, CA.
15. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000, 56(6):899-905. 10.1016/S0090-4295(00)00858-X, 11113727.
16. Denberg TD, Melhado TV, Steiner JF. Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote. Cancer 2006, 107(3):620-630. 10.1002/cncr.22033, 16802287.
17. Sommers BD, Beard CJ, D'Amico AV, Kaplan I, Richie JP, Zeckhauser RJ. Predictors of patient preferences and treatment choices for localized prostate cancer. Cancer 2008, 113(8):2058-2067. 10.1002/cncr.23807, 18704993.
18. Chen RC, Clark JA, Manola J, Talcott JA. Treatment 'mismatch' in early prostate cancer. Cancer 2008, 112(1):61-68. 10.1002/cncr.23138, 18040996.
19. O'Rourke ME. Narrowing the options: the process of deciding on prostate cancer treatment. Cancer Invest 1999, 17:349-359. 10.3109/07357909909032877, 10370363.
20. Sloan JA, Doig W, Yeung A. A manual to carry out Thurstone scaling and related analytic procdedures. Manitoba Nursing Research Institute Technical Report #11 1994, University of Manitoba, Winnipeg, Manitoba, Canada.
21. Barocas DA, Cowan JE, Smith JA, Carroll PR. What Percentage of Patients With Newly Diagnosed Carcinoma of the Prostate are Candidates for Surveillance? An Analysis of the CaPSURE(TM) Database. J Urol 2008, 180(4):1330-1335. 10.1016/j.juro.2008.06.019, 18707731.
22. Cooperberg MR, Broering JM, Carroll PR. Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer. J Clin Oncol 2010, 28(7):1117-1123. 10.1200/JCO.2009.26.0133, 2834465, 20124165.
23. Pickles T, Ruether JD, Weir L, Carlson L, Jakulj F, . the SCT Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. BJU Int 2007, 100(3):544-551. 10.1111/j.1464-410X.2007.06981.x, 17532857, the SCT.
24. Diefenbach MA, Dorsey J, Uzzo RG, Hanks GE, Greenberg RE, Horwitz E, Newton F, Engstrom PF. Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol 2002, 1:55-62.